Arrotex to shake-up Aussie pharma

Posted 5 September 2024 PM

In a major shake-up of the Australian pharmaceutical market, generics giant Arrotex is expanding into innovative medicines, nabbing a Novartis leader to head the new arm of the business.

Monique Jonson left Novartis last month after more than six years holding a number of senior positions to take up the newly created role of General Manager, Innovation at Arrotex.

To see the whole article, please login